• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HBV 相关肝细胞癌患者术后肝硬度变化的预后价值。

Prognostic value of postoperative change in liver stiffness in patients with HBV-related hepatocellular carcinoma.

机构信息

Department of Hepatology, Yantai Infectious Disease Hospital, Yantai, Shandong, China.

Department of Oncology, Yantai Yuhuangding Hospital, Yantai, Shandong, China.

出版信息

J Int Med Res. 2020 Apr;48(4):300060520908763. doi: 10.1177/0300060520908763.

DOI:10.1177/0300060520908763
PMID:32290747
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7158254/
Abstract

OBJECTIVE

To investigate the prognostic value of change in liver stiffness following surgery, in patients with hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC).

METHODS

Patients with HBV-related HCC were included. Preoperative (baseline) liver stiffness and postoperative dynamic change in liver stiffness was evaluated.

RESULTS

Out of 158 patients in total, postoperative liver stiffness was increased in 98 patients and decreased in 60 patients compared with baseline values. Kaplan-Meier analysis revealed that patients with elevated liver stiffness had significantly worse overall survival outcomes than those with decreased liver stiffness. Similar trends were observed for diseases-free survival and recurrence outcomes. Multivariate analyses showed that Child–Turcotte–Pugh score (hazard ratio [HR] 1.209) and liver stiffness changes (HR 1.891) were independent factors associated with overall survival. Liver stiffness changes (HR 1.521) and α-fetoprotein level (HR 1.210) were found to be independent factors for disease-free survival in patients with HCC.

CONCLUSION

Increased postoperative liver stiffness may be an independent risk factor of HCC prognosis. Patients with increased liver stiffness following surgery should undergo additional examinations during follow-up.

摘要

目的

探讨乙型肝炎病毒(HBV)相关肝细胞癌(HCC)患者术后肝硬度变化的预后价值。

方法

纳入 HBV 相关 HCC 患者。评估术前(基线)肝硬度和术后肝硬度的动态变化。

结果

在总共 158 例患者中,与基线值相比,98 例患者术后肝硬度增加,60 例患者术后肝硬度降低。Kaplan-Meier 分析显示,肝硬度升高的患者总生存结局明显差于肝硬度降低的患者。无病生存和复发结局也呈现出类似的趋势。多变量分析显示,Child–Turcotte–Pugh 评分(风险比 [HR] 1.209)和肝硬度变化(HR 1.891)是与总生存相关的独立因素。对于 HCC 患者,肝硬度变化(HR 1.521)和甲胎蛋白水平(HR 1.210)是无病生存的独立因素。

结论

术后肝硬度增加可能是 HCC 预后的独立危险因素。术后肝硬度增加的患者在随访期间应进行额外的检查。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09d/7158254/48a835e630c4/10.1177_0300060520908763-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09d/7158254/27fb721450fb/10.1177_0300060520908763-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09d/7158254/49a7bba506ec/10.1177_0300060520908763-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09d/7158254/48a835e630c4/10.1177_0300060520908763-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09d/7158254/27fb721450fb/10.1177_0300060520908763-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09d/7158254/49a7bba506ec/10.1177_0300060520908763-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09d/7158254/48a835e630c4/10.1177_0300060520908763-fig3.jpg

相似文献

1
Prognostic value of postoperative change in liver stiffness in patients with HBV-related hepatocellular carcinoma.HBV 相关肝细胞癌患者术后肝硬度变化的预后价值。
J Int Med Res. 2020 Apr;48(4):300060520908763. doi: 10.1177/0300060520908763.
2
Subcirrhotic liver stiffness by FibroScan correlates with lower risk of hepatocellular carcinoma in patients with HBV-related cirrhosis.经FibroScan检测的亚肝硬化肝硬度与乙肝相关肝硬化患者肝细胞癌风险较低相关。
Hepatol Int. 2017 May;11(3):268-276. doi: 10.1007/s12072-017-9789-y. Epub 2017 Feb 21.
3
Prognosis after resection of hepatitis B virus-related hepatocellular carcinoma originating from non-cirrhotic liver.非肝硬化肝脏来源的乙型肝炎病毒相关肝细胞癌切除术后的预后
Ann Surg Oncol. 2014 Jul;21(7):2406-12. doi: 10.1245/s10434-014-3505-0. Epub 2014 Feb 28.
4
The Severity of Liver Fibrosis Influences the Prognostic Value of Inflammation-Based Scores in Hepatitis B-Associated Hepatocellular Carcinoma.肝纤维化严重程度影响基于炎症的评分在乙型肝炎相关肝细胞癌中的预后价值。
Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1125-32. doi: 10.1245/s10434-015-4598-9. Epub 2015 Jul 10.
5
Clinical significance of preoperative liver stiffness measurements in primary HBV-positive hepatocellular carcinoma.术前肝脏硬度测量在原发性 HBV 阳性肝细胞癌中的临床意义。
Future Oncol. 2017 Dec;13(30):2799-2810. doi: 10.2217/fon-2017-0281. Epub 2017 Nov 30.
6
Molecular mechanistic insight of hepatitis B virus mediated hepatocellular carcinoma.乙型肝炎病毒导致肝细胞癌的分子机制见解。
Microb Pathog. 2019 Mar;128:184-194. doi: 10.1016/j.micpath.2019.01.004. Epub 2019 Jan 3.
7
Hepatocellular carcinoma (HCC) in a patient with hepatitis B virus (HBV) infection.一名感染乙肝病毒(HBV)的患者发生肝细胞癌(HCC)。
Am J Transplant. 2012 Mar;12(3):786-7; quiz 788. doi: 10.1111/j.1600-6143.2012.03979.x.
8
Relationship of hepatocellular carcinoma, liver cirrhosis, and hepatitis B virus. A pathologic study of 1,069 autopsy cases in different areas of China.肝细胞癌、肝硬化与乙型肝炎病毒的关系。对中国不同地区1069例尸检病例的病理学研究。
Chin Med J (Engl). 1984 Oct;97(10):758-64.
9
Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.增殖标志物Ki-67和p53蛋白在HBV或HCV肝硬化中的肝脏表达与发育异常肝细胞变化及肝细胞癌的关系。
J Viral Hepat. 2005 Nov;12(6):635-41. doi: 10.1111/j.1365-2893.2005.00635.x.
10
Expression of P62 in hepatocellular carcinoma involving hepatitis B virus infection and aflatoxin B1 exposure.P62 在乙型肝炎病毒感染和黄曲霉毒素 B1 暴露相关的肝细胞癌中的表达。
Cancer Med. 2017 Oct;6(10):2357-2369. doi: 10.1002/cam4.1176. Epub 2017 Sep 21.

引用本文的文献

1
Effectiveness of TKI Inhibitors Combined With PD-1 in Patients With Postoperative Early Recurrence of HCC: A Real-World Study.TKI抑制剂联合PD-1治疗肝癌术后早期复发患者的疗效:一项真实世界研究
Front Oncol. 2022 Mar 31;12:833884. doi: 10.3389/fonc.2022.833884. eCollection 2022.

本文引用的文献

1
Antiviral therapy improves post-operative survival outcomes in patients with HBV-related hepatocellular carcinoma of less than 3 cm - A retrospective cohort study.抗病毒治疗可改善 3cm 以下乙肝相关肝细胞癌患者的术后生存结局——一项回顾性队列研究。
Am J Surg. 2020 Apr;219(4):717-725. doi: 10.1016/j.amjsurg.2019.05.016. Epub 2019 Jun 13.
2
Altered epidermal fatty acid-binding protein expression in hepatocellular carcinoma predicts unfavorable outcomes.肝细胞癌中表皮脂肪酸结合蛋白表达改变预示不良预后。
Cancer Manag Res. 2018 Nov 23;10:6275-6284. doi: 10.2147/CMAR.S181555. eCollection 2018.
3
Radiotherapy for Hepatocellular Carcinoma in Russia: a Survey-Based Analysis of Current Practice and the Impact of an Educational Workshop on Clinical Expertise.
俄罗斯肝细胞癌的放射治疗:基于调查的当前实践分析以及教育研讨会对临床专业知识的影响
J Cancer Educ. 2020 Feb;35(1):105-111. doi: 10.1007/s13187-018-1447-0.
4
Management of fibrolamellar hepatocellular carcinoma.纤维板层型肝细胞癌的管理
Chin Clin Oncol. 2018 Oct;7(5):51. doi: 10.21037/cco.2018.08.08.
5
Epidemiology and Management of Hepatocellular Carcinoma.原发性肝癌的流行病学和管理。
Gastroenterology. 2019 Jan;156(2):477-491.e1. doi: 10.1053/j.gastro.2018.08.065. Epub 2018 Oct 24.
6
Decreased expression of peroxisome proliferator-activated receptor alpha indicates unfavorable outcomes in hepatocellular carcinoma.过氧化物酶体增殖物激活受体α表达降低表明肝细胞癌预后不良。
Cancer Manag Res. 2018 Jun 26;10:1781-1789. doi: 10.2147/CMAR.S166971. eCollection 2018.
7
Risk factors associated with liver steatosis and fibrosis in chronic hepatitis B patient with component of metabolic syndrome.伴有代谢综合征成分的慢性乙型肝炎患者肝脂肪变性和纤维化的相关危险因素。
United European Gastroenterol J. 2018 May;6(4):558-566. doi: 10.1177/2050640617751252. Epub 2018 Jan 16.
8
AFP role in predicting recurrence of hepatocellular carcinoma after living donor liver transplantation in HCV patients.AFP 在预测 HCV 患者活体肝移植后肝细胞癌复发中的作用。
Neoplasma. 2018 Mar 14;65(3):455-460. doi: 10.4149/neo_2018_170315N184.
9
Serum hepatitis B core antibody levels predict HBeAg seroconversion in chronic hepatitis B patients with high viral load treated with nucleos(t)ide analogs.血清乙肝核心抗体水平可预测接受核苷(酸)类似物治疗的高病毒载量慢性乙型肝炎患者的HBeAg血清学转换。
Infect Drug Resist. 2018 Apr 3;11:469-477. doi: 10.2147/IDR.S163038. eCollection 2018.
10
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.欧洲肝脏研究学会临床实践指南:肝细胞癌的管理
J Hepatol. 2018 Jul;69(1):182-236. doi: 10.1016/j.jhep.2018.03.019. Epub 2018 Apr 5.